Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
Adolescent
Adult
Aged
Aged, 80 and over
Cerebral Hemorrhage
/ classification
Cerebrovascular Disorders
/ classification
Databases, Factual
Female
Humans
International Classification of Diseases
Intracranial Hemorrhages
/ classification
Italy
/ epidemiology
Male
Middle Aged
Stroke
/ classification
Subarachnoid Hemorrhage
/ classification
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
08
2019
accepted:
22
12
2019
entrez:
10
1
2020
pubmed:
10
1
2020
medline:
21
4
2020
Statut:
epublish
Résumé
Validation of administrative databases for cerebrovascular diseases is crucial for epidemiological, outcome, and health services research. The aim of this study was to validate ICD-9 codes for hemorrhagic or ischemic stroke in administrative databases, to use them for a comprehensive assessment of the burden of disease in terms of major outcomes, such as mortality, hospital readmissions, and use of healthcare resources. We considered the hospital discharge abstract database of the Umbria Region (890,000 residents). Source population was represented by patients aged >18 discharged from hospital with a diagnosis of hemorrhagic or ischemic stroke between 2012 and 2014 using ICD-9-CM codes in primary position. We randomly selected and reviewed medical charts of cases and non-cases from hospitals. For case ascertainment we considered symptoms and instrumental tests reported in the medical charts. Diagnostic accuracy measures were computed using 2x2 tables. We reviewed 767 medical charts for cases and 78 charts for non-cases. Diagnostic accuracy measures were: subarachnoid hemorrhage: sensitivity (SE) 100% (95% CI: 97%-100%), specificity (SP) 96% (90-99), positive predictive value (PPV) 98% (93-100), negative predictive value (NPV) 100% (95-100); intracerebral hemorrhage: SE 100% (97-100), SP 98% (91-100), PPV 98% (94-100), NPV 100% (95-100); other and unspecified intracranial hemorrhage: SE 100% (97-100), SP 96% (90-99), PPV 98% (93-100), NPV 100% (95-100); ischemic stroke due to occlusion and stenosis of precerebral arteries: SE 99% (94-100), SP 66 (57-75), PPV 70% (61-77), NPV 99% (93-100); occlusion of cerebral arteries: SE 100% (97-100), SP 87% (78-93), PPV 91% (84-95), NPV 100% (95-100); acute, but ill-defined, cerebrovascular disease: SE 100% (97-100), SP 78% (69-86), PPV % 83 (75-89), NPV 100% (95-100). Case ascertainment for both ischemic and hemorrhagic stroke showed good or high levels of accuracy within the regional healthcare databases in Umbria. This database can confidently be employed for epidemiological, outcome, and health services research related to any type of stroke.
Sections du résumé
BACKGROUND
Validation of administrative databases for cerebrovascular diseases is crucial for epidemiological, outcome, and health services research. The aim of this study was to validate ICD-9 codes for hemorrhagic or ischemic stroke in administrative databases, to use them for a comprehensive assessment of the burden of disease in terms of major outcomes, such as mortality, hospital readmissions, and use of healthcare resources.
METHODS
We considered the hospital discharge abstract database of the Umbria Region (890,000 residents). Source population was represented by patients aged >18 discharged from hospital with a diagnosis of hemorrhagic or ischemic stroke between 2012 and 2014 using ICD-9-CM codes in primary position. We randomly selected and reviewed medical charts of cases and non-cases from hospitals. For case ascertainment we considered symptoms and instrumental tests reported in the medical charts. Diagnostic accuracy measures were computed using 2x2 tables.
RESULTS
We reviewed 767 medical charts for cases and 78 charts for non-cases. Diagnostic accuracy measures were: subarachnoid hemorrhage: sensitivity (SE) 100% (95% CI: 97%-100%), specificity (SP) 96% (90-99), positive predictive value (PPV) 98% (93-100), negative predictive value (NPV) 100% (95-100); intracerebral hemorrhage: SE 100% (97-100), SP 98% (91-100), PPV 98% (94-100), NPV 100% (95-100); other and unspecified intracranial hemorrhage: SE 100% (97-100), SP 96% (90-99), PPV 98% (93-100), NPV 100% (95-100); ischemic stroke due to occlusion and stenosis of precerebral arteries: SE 99% (94-100), SP 66 (57-75), PPV 70% (61-77), NPV 99% (93-100); occlusion of cerebral arteries: SE 100% (97-100), SP 87% (78-93), PPV 91% (84-95), NPV 100% (95-100); acute, but ill-defined, cerebrovascular disease: SE 100% (97-100), SP 78% (69-86), PPV % 83 (75-89), NPV 100% (95-100).
CONCLUSIONS
Case ascertainment for both ischemic and hemorrhagic stroke showed good or high levels of accuracy within the regional healthcare databases in Umbria. This database can confidently be employed for epidemiological, outcome, and health services research related to any type of stroke.
Identifiants
pubmed: 31918434
doi: 10.1371/journal.pone.0227653
pii: PONE-D-19-24032
pmc: PMC6952250
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0227653Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Rehabil Res Dev. 2001 Mar-Apr;38(2):281-9
pubmed: 11392661
Cerebrovasc Dis. 2008;25(5):457-507
pubmed: 18477843
BMJ Open. 2018 Apr 20;8(4):e020631
pubmed: 29678984
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
BMJ Open. 2016 Jun 01;6(6):e011777
pubmed: 27251687
BMJ. 2003 Jul 5;327(7405):18-22
pubmed: 12842950
PLoS One. 2015 Aug 20;10(8):e0135834
pubmed: 26292280
Stroke. 1995 Mar;26(3):355-60
pubmed: 7886706
BMJ Open. 2016 Mar 25;6(3):e010547
pubmed: 27016247
BMJ Open. 2018 May 17;8(5):e020628
pubmed: 29773701
Neurol Sci. 2004 Dec;25(5):281-8
pubmed: 15624086
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
Neurol Sci. 2003 Jun;24(2):65-9
pubmed: 12827541
Eur J Clin Pharmacol. 2003 Nov;59(8-9):659-61
pubmed: 14508622
Eur J Clin Pharmacol. 1998 Jul;54(5):393-7
pubmed: 9754982
BMJ Open. 2016 Sep 15;6(9):e011776
pubmed: 27633635
BMJ Open. 2018 Jul 23;8(7):e020627
pubmed: 30037866
Stroke. 2005 May;36(5):1031-4
pubmed: 15790948
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Stroke. 2013 Mar;44(3):870-947
pubmed: 23370205
JAMA. 2001 Apr 11;285(14):1840-1
pubmed: 11308395
BMJ Open. 2018 Jul 5;8(7):e020630
pubmed: 29980543
Int J Stroke. 2011 Jun;6(3):219-27
pubmed: 21557809
BMJ Open. 2016 Mar 18;6(3):e010409
pubmed: 26993624
BMJ Open. 2017 Mar 29;7(3):e013785
pubmed: 28360241
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:100-28
pubmed: 22262598